Quantcast
Last updated on April 21, 2014 at 5:21 EDT

Latest Beta amyloid Stories

2013-05-07 16:18:57

Scientists´ picture of how a gene strongly linked to Alzheimer´s disease harms the brain may have to be revised, researchers at Washington University School of Medicine in St. Louis have found. People with harmful forms of the APOE gene have up to 12 times the risk of developing Alzheimer´s disease compared with those who have other variations of the gene. Many researchers believe that the memory loss and cognitive problems of Alzheimer´s result from the buildup over...

2013-05-07 12:31:35

BERLIN, BOSTON and MUMBAI, India, May 7, 2013 /PRNewswire/ -- Piramal Imaging SA, a division of Piramal Enterprises, today announced Ana M. Catafau, M.D., Ph.D., has joined the company as vice president (VP) of Clinical Research and Development, Neurosciences. (Logo: http://photos.prnewswire.com/prnh/20130507/NE09018LOGO) Dr. Catafau's appointment comes on the heels of Piramal Imaging's announcement that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA)...

2013-05-06 08:30:03

--After Successful Pre-IND Meeting, Company On Track to Advance Lead Compound NPT002 into Clinical Trials for Alzheimer's Disease in 2014-- CAMBRIDGE, Mass., May 6, 2013 /PRNewswire/ -- NeuroPhage Pharmaceuticals, Inc., a company developing breakthrough therapies for neurodegenerative diseases, today announced that it raised $6.4 million in a private equity financing round. Merieux Developpement led the financing with participation from all current Neurophage investors, including...

Researchers Find Alzheimer’s Biomarkers
2013-05-01 14:21:32

Brett Smith for redOrbit.com - Your Universe Online Researchers from Australia´s Commonwealth Scientific and Industrial Research Organisation“¯(CSIRO) are reporting significant progress in developing a blood test that can predict the onset of Alzheimer´s in an individual. According to their report in the journal Molecular Psychiatry, the researchers said they have identified several biomarkers that are associated with the toxic build-up of beta amyloid, a brain...

Alzheimer's Disease: Protective Gene Variant Sheds Light On Potential New Treatment
2013-04-26 04:44:04

redOrbit Staff & Wire Reports - Your Universe Online New research published Thursday in the journal Neuron sheds new light on the molecular causes of Alzheimer´s disease, while also revealing a potential new therapy which could help prevent cognitive decline and brain damage during the early stages of the neurodegenerative disorder. The study focuses on a variant of a gene known as CD33, which typically contributes to Alzheimer´s disease by inhibiting the ability of a...

2013-04-22 08:20:01

New IBN Peptides May Help Researchers Combat Alzheimer's, Diabetes and CancerSingapore, Apr 22, 2013 - (ACN Newswire) - Amyloids, or fibrous aggregates of abnormally folded proteins, are a common feature in degenerative diseases such as Alzheimer's, diabetes and cancer. Amyloids occur naturally in the body, but despite decades of research, their mechanism of formation remains unknown, hampering drug development efforts. Now, a new class of ultrasmall peptides developed by the Institute of...

2013-04-18 21:49:11

TAU reveals the missing link between brain patterns and Alzheimer's Evidence indicates that the accumulation of amyloid-beta proteins, which form the plaques found in the brains of Alzheimer's patients, is critical for the development of Alzheimer's disease, which impacts 5.4 million Americans. And not just the quantity, but also the quality of amyloid-beta peptides is crucial for Alzheimer's initiation. The disease is triggered by an imbalance in two different amyloid species – in...

2013-04-18 12:15:11

Close family members of people with Alzheimer's disease are more than twice as likely as those without a family history to develop silent buildup of brain plaques associated with Alzheimer's disease, according to researchers at Duke Medicine. The study, published online in the journal PLOS ONE on April 17, 2013, confirms earlier findings on a known genetic variation that increases one's risk for Alzheimer's, and raises new questions about other genetic factors involved in the disease that...

2013-04-17 08:29:34

Investment is an Important Advancement in the Company's Long-term Commitment to Bringing New Medicines to Millions of Alzheimer's Disease Patients Who Are Waiting INDIANAPOLIS, April 17, 2013 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced it has acquired two investigational positron emission tomography (PET) tracers from Siemens Medical Solutions USA, Inc. The tracers are intended to image tau (or neurofibrillary) tangles in the brain, one of two known hallmarks...

2013-04-10 10:54:07

New rat model will advance Alzheimer's research A new genetically engineered lab rat that has the full array of brain changes associated with Alzheimer's disease supports the idea that increases in a molecule called beta-amyloid in the brain causes the disease, according to a study, published in the Journal of Neuroscience. The study was supported by the National Institutes of Health. "We believe the rats will be an excellent, stringent pre-clinical model for testing experimental...